Table 7. The efficacy of second line therapies for H. pylori eradication .
Year | City | First Regimen | Second Regimen | Number of Patients | Per-protocol Eradication Rate |
2001 | Tehran73 | OABM | OTBF | 80 | 90 |
2003 | Tehran74 | OABM | OABF | 90 | 78.7 |
2010 | Isfahan75 | OABM |
OABC OAzBOf |
110 110 |
74.7 86.7 |
2012 | Sari37 | Sequential |
OABF (F: 7days) |
36 | 82.9 |
2015 | Rasht52 | OABM |
OBTMOf OABCT |
104 104 |
86.7 76 |
2016 | Sari77 |
OABM OABF |
OABC OABC |
32 31 |
87 82.7 |
2016 | Sari79 |
Non-bismuth clarithromycin-containing |
PAL | 61 | 91.8 |
O: Omeprazole, Amox: Amoxicillin, B: Bismuth subcitrate, Tetra: Tetracycline, M: Metronidazole, C: Clarithromycin, F: Furazolidone, Of: Ofloxacin, Az: Azithromycin